Floatz logo

VITAMIN D

Glioblastoma Multiforme

Soroka University Medical CentermixturePhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

47 Active assets in the Glioblastoma Multiforme cohort.

Asset / SponsorPhaseRating
Depatuxizumab Mafodotin
AbbVie
Phase 3BB
Cintredekin Besudotox
INSYS Therapeutics Inc
Phase 3BB
CARMUSTINE
Leland Metheny
Phase 3BB
Carboplatin
Sichuan Honghe Biotechnology Co., Ltd.
Phase 3BB
Valaciclovir
Trogenix ltd
Phase 2BB

View all 50 →

Same molecule, other indications

VITAMIN D is also rated in:

vitamin D deficiencyDormant
A
Indicative ·
83 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →